To investigate the expression of a marker of cell proliferation (MIB-1) and its puta tive relationship with tumor size, histologic grading, mitotic index, nodal status, estrogen receptor content, p53 immunoreactivity, and ploidy, we studied 40 cases of invasive breast carcinoma in formalin-fixed, paraffin-embedded tissue sections. The MIB-1, estrogen receptor, and p53 were detected using an avidin-biotin-peroxidase method with microwave antigen retrieval. Ploidy was assessed by image analysis. The median value of MIB-1 index was 15.9% and ranged from 5% to 90%. We found a significant and positive relationship among the MIB-1 index and histologic grading, mitotic index, p53 immunoreactivity, and ploidy, and we demonstrated an inverse relationship between the MIB-1 index and estrogen receptor content. These " results are similar to those reported using Ki-67 in frozen sections from breast car cinomas. Thus, MIB-1 detected in formalin-fixed material with microwave pre treatment looks to be a reliable marker of proliferation in breast carcinomas. Int J Surg Pathol 2(4):287-294, 1995
Kamel OW, Franklin WA, Ringus JC, Meyer JSThymidine labeling index and Ki-67 growth fraction in lesions of the breast . Am J Pathol134:107-113, 1989
2.
Lloveras B., Edgerton S., Thor ADEvaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit. Am J Clin Pathol95:41-47, 1991
3.
Isola JJ, Helin HJ, Helle MJ, Kallioniemi OPEvaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis and mitotic count . Cancer65:1180-1184, 1990
4.
Leonardi E., Girlando S., Serio G., Mauri FA, Perrone G., Scampini S., Dalla Palma P, Barbareschi M.PCNA and Ki-67 expression in breast carcinoma: Correlations with clinical and biological variables. J Clin Pathol45:416-419, 1992
5.
Tahan SR, Neuberg DS, Dieffenbach A., Yacoub L.Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer71:3552-3559, 1993
6.
Haerslev T., Jacobsen GKProliferating cell nuclear antigen in breast carcinomas: An immunohistochemical study with correlation to histopathological features and prognostic factors . Virchows Arch [A]424:39-46, 1994
7.
Schmitt FC, Pereira EM, Andrade LM, Torresan M., De Lucca L.Proliferative activity in paraffin-embedded sections of breast carcinoma detected by monoclonal antibody PC 10 does not correlate with mitotic index and estrogen receptor immunoreactivity. Pathol Res Pract190:786-791, 1994
8.
Veronese SM, Gambacorta M.Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features. Am J Clin Pathol95:30-34, 1991
9.
Bilous AM, McKay M., Milliken J.A comparison between Ki-67 antibody reactivity and other pathological variables in breast carcinoma. Pathology23:282-285, 1991
10.
Bouzobar N. , Walker KJ, Griffiths K., Ellis IO, Elston CW, Robertson JF, Blamey RW, Nicholson RIKi67 immunostaining in primary breast cancer: Pathological and clinical associations. Br J Cancer59:943-947, 1989
11.
Sahin AA, Ro J., Ro JY, Blick MB, El-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AGKi-67 immunostaining in node-negative stage I/II breast carcinoma: Significant correlation with prognosis. Cancer68:549-557, 1991
12.
Wintzer HO, Zipfel I., Schulte-Monting J., Hellerich V., Kleist S.Ki-67 immunostaining in human breast tumors and its relationship to prognosis . Cancer67:421-428, 1991
13.
Barbareschi M., Leonardi E., Mauri FA, Serio G., Palma PDp53 and c-erbB-2 protein expression in breastcarcinomas: An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer. Am J Clin Pathol98:408-418, 1992
14.
Gerdes J., Li L., Schluter C., Duchrow M., Wohlenberg C., Geriach C., Stahmer I., Kloth S., Brandt E., Flad HDImmunobiochemical and molecular biologic characterization of the cell-proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol138:867-873, 1991
15.
McCormick D. , Chong H., Hobbs C., Datta C., Hall PADetection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1. Histopathology22:355-360, 1993
16.
Key G., Becker Mhg, Baron B., Duchrow M., Schlüter C, Flad HD, Gerdes J. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest68:629-636, 1993
17.
Bloom Hjg, Richardson WWHistological grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer9:359-377, 1957
18.
Van Diest PJ , Baak JP, Matze-Cok P., Wisse-Brekelmans Ecm, Van Galen CM, Kurver Phj, Bellot SM, Fijnheer J, VanGorp LHM, Kwee WS, Los J, Peterse JL, Ruitenberg HM, Schapers RFM, Schipper MEI, Somsen JG, Willig AWPM, Ariens AT. Reproducibility of mitosis counting in 2469 breast cancer specimens: Results from the multi-center morphometric mammary carcinoma project. Hum Pathol23:603-607, 1992
19.
Bartek J., Bartkova J., Vojtesek B., Staskova Z., Rejthar A., Kovarik J., Lane DPPatterns of expression of the p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int J Cancer46:839-844, 1990
20.
Gaglia P., Bernardi A., Venesio T., Caldarola B., Lavro D., Cappa Apm, Calderini P., Liscia DSCell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrences. Eur J Cancer29A: 1509-1513, 1993
21.
Hall PA, Levison DA, Woods AL, Yu Ccw, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R., Dover R., Waseen NH, Lane DPProliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol162:285-294, 1990
22.
Bravo R., Frank R., Blundell PA, MacDonald-Bravo H. Cyclin/PCNA in the auxiliary protein of DNA polymerase-delta . Nature326:515-520, 1987
23.
McCormick D. , Hall PAThe complexities of proliferating cell nuclear antigen. Histopathology21: 591-594,1992
24.
McGurrin JF , Doria MI, Dawson PJ, Karrison T., Stew HO, Franklin WAAssessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer59:1744-1750, 1987
25.
Dawson AE, Norton JA, Weinberg DSComparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol136:1115-1124, 1990
26.
Hirano T., Franzén B., Kato H., Ebihara Y., Aver G.Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol144:296-302, 1994
